Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/06/2003US20030045473 L-arginine polypeptides thereofor salts or pro-forms and a second component selected from sterols, stanols, sterol esters, stanol esters, and polyol fatty acid polyesters; health bars
03/06/2003US20030045470 Methods and compositions for modulating gluconeogenesis using PGC-1
03/06/2003US20030045469 Treatment of congestive heart failure
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030045466 Calcium binding protein
03/06/2003US20030045465 RTransport polymer comprising a linear or branched peptide having 10-300 amino acid residues, having from about 5 to 100% histidine residues; drug delivery, especially gene therapy and cancer chemotherapy
03/06/2003US20030045464 From a crystallization solution comprising a GLP, a buffering agent, an alcohol or a mono or disaccharide, and optionally, ammonium sulfate or zinc.
03/06/2003US20030045463 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030045462 Also vectors and host cells comprising those nucleic acid sequences, chimeric molecules of these polypeptides fused to heterologous polypeptide sequences, antibodies which bind to these polypeptides
03/06/2003US20030045461 Composition and methods of esterified nitroxides gated with carboxylic acids
03/06/2003US20030045460 Orally administered peptides to ameliorate atherosclerosis
03/06/2003US20030045459 67 Human secreted proteins
03/06/2003US20030045458 Capable of directing supra-lethal doses of radiation, called Hot-Spots, virtually exclusively to the cancer.
03/06/2003US20030045457 Process for preparing glycopeptide derivatives
03/06/2003US20030045456 Complex comprising OCIF and polysaccharide
03/06/2003US20030045455 Method of using lectins for prevention and treatment of oral and alimentary tract disorders
03/06/2003US20030045454 Sustained release formulation
03/06/2003US20030045453 Pharmaceutical composition for stimulation of the immune system
03/06/2003US20030044982 Expression vector coding blood coagulation protein for use in the treatment of blood disorders
03/06/2003US20030044979 Nucleotide sequences for use in the treatment of inflammation, cancer and immunological disorders
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044961 Compositions for transferring active compounds in a cell-specific manner
03/06/2003US20030044960 Picornaviruses, vaccines and diagnostic kits
03/06/2003US20030044959 Chromosome 17p-linked prostrate cancer susceptibility gene and a paralog and orthologous genes
03/06/2003US20030044953 Novel telomerase
03/06/2003US20030044950 Phosphodiesterase 10
03/06/2003US20030044948 56919, A novel human acyltransferase and uses thereof
03/06/2003US20030044945 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044941 Genetically engineering preferential nucleotide sequences; obtain nucleotide sequences, incubate with probe, incubate with ribonuclease, recover adjusted nucleotide sequences
03/06/2003US20030044935 Secreted proteins and polynucleotides encoding them
03/06/2003US20030044915 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
03/06/2003US20030044913 Extracellular matrix and cell adhesion molecules
03/06/2003US20030044911 Nucleotide sequences coding polypeptide for use in the treatment tumors, nervous system and cardiovascular disorders
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044908 Coagulation factor VII derivatives
03/06/2003US20030044905 Nucleic acids, proteins, and antibodies
03/06/2003US20030044903 Modified target enzymes having catalytic triads and uses thereof
03/06/2003US20030044902 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of skin and tumor disorders
03/06/2003US20030044901 Polypeptide for use in animal models associated with human therapeutics
03/06/2003US20030044899 Isolated laminin 10
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044895 Nucleotide sequences coding polypeptide for use in t he treatment of tumors, respiratory and liver disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044892 Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestine
03/06/2003US20030044890 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's disease and brain disorders
03/06/2003US20030044889 Human HAC3
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044860 Diagnosing prostate cancer in humans; obtain body fluid sample, detect expression of insulin-like growth factor in body fluid, compare to control, an amplified concentration of insulin-like growth factor indicates prostate cancer
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044858 Anti-IgE antibodies
03/06/2003US20030044852 Detecting modulator of diabetic defects; obtain cells, incubate with modulator, monitor cell response to modulator, evaluate for insulin resistance
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044844 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044842 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044838 Generation of peptides which bind bacterial spores; btain phage, incubate with spore, centrifuge, wash, elute, amplify eluted phage, purifying clones, amplify clones, extract nucleotide sequences incubate with peptide, monitor binding
03/06/2003US20030044814 Diagnosing cancer in humans; obtain tissue, detect presence of marker polypeptide, monitor concentration, amplified concentration of marke protein indicates cancer
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044812 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of cancer
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044803 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of lymphoma and leukemia
03/06/2003US20030044793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/06/2003US20030044792 Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides
03/06/2003US20030044788 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
03/06/2003US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide
03/06/2003US20030044770 Methods for using resonance energy transfer- based assay of hiv-1 envelope gylcoprotein-mediated membrane fusion, and kits for practicing same
03/06/2003US20030044468 Shaping polymeric precursors by inducing thermal gelation of an aqueous solution thereof and then curing said precursors by crosslinking reactive groups; biomedical uses include drug delivery, microencapsulation, implantation
03/06/2003US20030044467 Gel composition and methods
03/06/2003US20030044466 Oral drug delivery systems where drug is administered with any of specified substances that induce "fed mode" in stomach such as tryptophan dipeptide or cetylpyridinium chloride to prolong retention in stomach; bioavailability
03/06/2003US20030044463 Sustained release of microcrystalline peptide suspensions
03/06/2003US20030044452 Composition for topical administration
03/06/2003US20030044446 A multilayered film comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time; drug delivery from mouth
03/06/2003US20030044439 Treatment of skin with adenosine or adenosine analog
03/06/2003US20030044438 Adapted for improving skin ageing and/or photoageing signs, which cutaneous signs are directly a result of a chronic micro-inflammatory process induced by repeated UV exposures
03/06/2003US20030044427 Compositions and methods for treating Papillomavirus-infected cells
03/06/2003US20030044426 Attenuated pestiviruses
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/06/2003US20030044418 Use of SdrG, a fibrinogen-binding bacterial adhesin or its binding region as an anti-coagulation agent by virtue of its ability to inhibit thrombin-induced fibrin clot formation by interfering with release of fibrinopeptide B
03/06/2003US20030044416 Nucleic acids encoding cd100 molecules
03/06/2003US20030044415 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
03/06/2003US20030044410 Neutralization interferons, tumor necrosis factor
03/06/2003US20030044408 Surface modification for improving biocompatibility
03/06/2003US20030044405 Sustained release; drug delivery; tissue adhesive
03/06/2003US20030044404 Regulation of angiogenesis with zinc finger proteins
03/06/2003US20030044403 Anti-infective therapy
03/06/2003US20030044402 Oligo(ethylene glycol)-terminated 1,2-dithiolanes and their conjugates useful for preparing self-assembled monolayers
03/06/2003US20030044401 Anticancer agents; prevent drug resistance
03/06/2003US20030044400 Administering glycoproteins, fetuin; antiaging agents, bone disorders, anticancer agents
03/06/2003US20030044399 Method of treatment
03/06/2003US20030044392 Gene therapy; prevent transformation of cells
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030044385 Antitumor, anticancer agents
03/06/2003US20030044384 Treatment of neoplasms with viruses
03/06/2003US20030044383 Tissue specific adenoviral vectors
03/06/2003US20030041602 Process for production of nanoparticles and microparticles by spray freezing into liquid
03/06/2003CA2496180A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003CA2494870A1 Methods for inhibiting angiogenesis
03/06/2003CA2465676A1 Compositions and techniques for localized therapy of restenosis
1 ... 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 ... 3163